IRIS
CHISARI, CLARA GRAZIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.667
AS - Asia 3.330
EU - Europa 3.014
SA - Sud America 537
AF - Africa 516
Continente sconosciuto - Info sul continente non disponibili 232
OC - Oceania 3
Totale 13.299
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.467
SG - Singapore 1.646
RU - Federazione Russa 1.177
CN - Cina 854
IT - Italia 802
BR - Brasile 449
IE - Irlanda 339
CI - Costa d'Avorio 293
VN - Vietnam 268
KR - Corea 170
FR - Francia 147
CA - Canada 125
UA - Ucraina 123
BD - Bangladesh 99
GB - Regno Unito 84
DE - Germania 83
IN - India 70
NG - Nigeria 64
SN - Senegal 63
SE - Svezia 51
NL - Olanda 50
FI - Finlandia 38
MX - Messico 38
ZA - Sudafrica 34
TR - Turchia 32
PL - Polonia 31
AR - Argentina 26
HK - Hong Kong 25
IQ - Iraq 25
JP - Giappone 22
BJ - Benin 21
ES - Italia 20
VE - Venezuela 18
UZ - Uzbekistan 17
CH - Svizzera 16
PK - Pakistan 16
EC - Ecuador 14
AE - Emirati Arabi Uniti 11
ID - Indonesia 11
JM - Giamaica 10
EG - Egitto 9
KE - Kenya 9
AT - Austria 8
CL - Cile 8
CO - Colombia 7
MA - Marocco 7
PY - Paraguay 7
SA - Arabia Saudita 7
TH - Thailandia 7
CZ - Repubblica Ceca 6
JO - Giordania 6
MY - Malesia 6
NP - Nepal 6
PE - Perù 6
TN - Tunisia 6
BG - Bulgaria 5
HR - Croazia 5
IR - Iran 5
LT - Lituania 5
TT - Trinidad e Tobago 5
AZ - Azerbaigian 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
GR - Grecia 4
IL - Israele 4
AU - Australia 3
ET - Etiopia 3
LV - Lettonia 3
NI - Nicaragua 3
PH - Filippine 3
SV - El Salvador 3
XK - ???statistics.table.value.countryCode.XK??? 3
AL - Albania 2
AO - Angola 2
BE - Belgio 2
DM - Dominica 2
EU - Europa 2
KG - Kirghizistan 2
KZ - Kazakistan 2
LB - Libano 2
MD - Moldavia 2
MT - Malta 2
OM - Oman 2
PA - Panama 2
RO - Romania 2
AF - Afghanistan, Repubblica islamica di 1
AM - Armenia 1
BB - Barbados 1
BO - Bolivia 1
BS - Bahamas 1
BY - Bielorussia 1
CR - Costa Rica 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
HU - Ungheria 1
IM - Isola di Man 1
KW - Kuwait 1
KY - Cayman, isole 1
LK - Sri Lanka 1
Totale 13.061
Salva come PNG Salva come JPEG
Città #
Singapore 1.010
Dallas 950
Santa Clara 698
Moscow 516
San Jose 466
Chandler 445
Ashburn 331
Dublin 331
Abidjan 292
Hefei 256
Chicago 233
Council Bluffs 185
Catania 169
Seoul 168
Los Angeles 145
Boardman 138
Beijing 116
Lauterbourg 108
Jacksonville 107
Civitanova Marche 90
Cambridge 80
Lawrence 79
Andover 76
Ho Chi Minh City 75
New York 72
Dakar 63
Nanjing 60
Saint Petersburg 60
Hanoi 55
Toronto 55
São Paulo 52
Buffalo 48
Des Moines 48
Lagos 33
Milan 33
Bremen 32
Rome 32
Houston 29
Orem 29
Abuja 26
Denver 26
Dong Ket 26
Warsaw 25
Hong Kong 24
Montreal 24
San Francisco 24
Wilmington 24
Johannesburg 23
Lappeenranta 23
Amsterdam 22
Cotonou 21
Phoenix 20
Tokyo 20
Columbus 19
London 19
Palermo 19
Brooklyn 17
Nanchang 17
Shenyang 17
Mexico City 16
Stockholm 16
The Dalles 16
Chennai 15
Naples 15
Rio de Janeiro 15
Seattle 15
Belo Horizonte 14
Da Nang 13
Hebei 13
Poplar 13
Atlanta 12
Manchester 12
Mascalucia 12
Munich 12
Ottawa 11
Redwood City 11
Ankara 10
Bernareggio 10
Charlotte 10
Florence 10
Haiphong 10
Helsinki 10
Kiev 10
Mumbai 10
San Mateo 10
Abu Dhabi 9
Baghdad 9
Frankfurt am Main 9
Miami 9
Tashkent 9
Washington 9
Boston 8
Brasília 8
Giarre 8
Istanbul 8
Philadelphia 8
Porcari 8
Porto Alegre 8
Rende 8
Turin 8
Totale 8.648
Salva come PNG Salva come JPEG
Nome #
The ocular ecosystem in the discoid lupus erythematosus 235
Different patterns of acute saccadic response to levodopa in de novo Parkinson’s disease 192
Early Intensive Versus Escalation Approach: Ten‐Year Impact on Disability in Relapsing Multiple Sclerosis 186
After the sweet comes the bitter. Time to halt the diabetic neuropathy epidemic 181
Cancer Risk and Multiple Sclerosis: Evidence From a Large Italian Cohort 175
Amyotrophic lateral sclerosis: differential diagnosis with cervical myeloradiculopathy 169
Efficacy and safety of extracranial vein angioplasty in multiple sclerosis: A randomized clinical trial 167
Aging eye microbiota in dry eye syndrome in patients treated with enterococcus faecium and saccharomyces boulardii 166
An update on the safety of treating relapsing-remitting multiple sclerosis 156
Effectiveness and safety of Rituximab in demyelinating diseases spectrum: An Italian experience 154
Functional stress and microbiota eye in subjects with type 2 diabetes: a multifactorial approach 152
An update on the pharmacological management of pain in patients with multiple sclerosis 149
Cancer risk assessment in multiple sclerosis patients in the Eastern Sicily 143
Retinal Thickness and Microvascular Pattern in Early Parkinson's Disease 143
Microbiological Etiology of Chronic skin lesions in type 2 Diabetic Subjects 142
Clinical bacteriological aspects of the Human Amniotic Membrane in the diabetic foot. A case report 139
Amniotic membrane use in type 2 diabetes patients with chronic ulcers: Microbiological evaluation and therapeutic benefits 139
Retinal Thickness in Essential Tremor and Early Parkinson Disease: Exploring Diagnostic Insights 138
CSF neurotoxic metals/metalloids levels in amyotrophic lateral sclerosis patients: comparison between bulbar and spinal onset 138
Are oligoclonal bands associated to lower retinal layer thickness at the time of relapsing remitting multiple sclerosis diagnosis? Evidence from an exploratory study 135
Lack of association between Toxocara canis and multiple sclerosis: A population-based case-control study 134
An update on idiopathic intracranial hypertension in adults: a look at pathophysiology, diagnostic approach and management 133
A multicenter, observational, prospective study of self- and parent-reported quality of life in adolescent multiple sclerosis patients self-administering interferon-β1a using RebiSmartâ ¢â the FUTURE study 132
Real-World Effectiveness of Cladribine for Patients with Multiple Sclerosis: A Sicilian Multicentric Experience (Rewind Study) 129
Functional Neurological disorders; those bizarre and painfull disconnections between brain and body 129
Early-Onset Alcohol Dependence and Multiple Sclerosis: Diagnostic Challenges 129
Clinical-Instrumental patterns of neurodegeneration in Essential Tremor: A data-driven approach 128
A dynamic interpretation of κFLC index for the diagnosis of multiple sclerosis: a change of perspective 126
Lateral switch to IFN beta-1a 44 mcg may be effective as escalation switch to fingolimod in selected persons with relapsing remitting multiple sclerosis: a real-world setting experience 126
Effects of Nintendo Wii Fit® balance exercise program on physical abilities and quality of life in Multiple Sclerosis patients 123
Administration of subcutaneous interferon beta 1a in the evening: data from RELIEF study 119
Active and non-active secondary progressive multiple sclerosis patients exhibit similar disability progression: results of an Italian MS registry study (ASPERA) 119
The Italian Multiple Sclerosis Register Experience With Cladribine 118
A real-world evidence study of nabiximols in multiple sclerosis patients with resistant spasticity: Analysis in relation to the newly described 'spasticity-plus syndrome' 118
No evidence of disease activity (NEDA-3) and disability improvement after alemtuzumab treatment for multiple sclerosis: a 36-month real-world study 118
Changes in Anti-JCV Antibody Status in a Large Population of Multiple Sclerosis Patients Treated with Natalizumab 118
Gonadal Steroids and Sperm Quality in a Cohort of Relapsing Remitting Multiple Sclerosis: A Case-Control Study 118
Inpatient versus outpatient rehabilitation for multiple sclerosis patients: effects on disability and quality of life 116
Cilostazol reduces dry eye symptoms and improve walking distance in patients with peripheral artery disease 115
Late-onset and young-onset relapsing-remitting multiple sclerosis: evidence from a retrospective long-term follow-up study 115
Dimethyl fumarate vs Teriflunomide: an Italian time-to-event data analysis 115
Migraine causes retinal and choroidal structural changes: evaluation with ocular coherence tomography 114
Prevalence and Incidence of Multiple Sclerosis in the City of Biancavilla 114
Etiology of chronic skin lesions in subjects with peripheral arterial disease 114
Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis Patients: Monocentric Case Series and Systematic Review of the Literature 112
Immunological Subsets Characterization in Newly Diagnosed Relapsing–Remitting Multiple Sclerosis 112
Palliative care in multiple sclerosis 111
First-year treatment response predicts the following 5-year disease course in patients with relapsing-remitting multiple sclerosis 110
Subclinical involvement of eye movements detected by video-based eye tracking in myasthenia gravis 109
Optic Nerve Head and Retinal Changes in Idiopathic Intracranial Hypertension: Correlation with Short-Term Cerebrospinal Fluid Pressure Monitoring 109
Changes in John Cunningham Virus Index in Multiple Sclerosis Patients Treated with Different Disease-Modifying Therapies 108
A model-based study of internuclear ophthalmoparesis and ocular-motor fatigue in multiple sclerosis 107
Factors driving delayed time to multiple sclerosis diagnosis: Results from a population-based study 107
Valutazione dell’efficacia clinica-batteriologica dell’ofloxacina e della levofloxacina nelle congiuntiviti batteriche 107
Efficacy of fingolimod and interferon beta-1b on cognitive, MRI, and clinical outcomes in relapsing–remitting multiple sclerosis: an 18-month, open-label, rater-blinded, randomised, multicentre study (the GOLDEN study) 107
Esposizione ad elementi in tracce in aree ad alta incidenza di sclerosi multipla: un ruolo delle ceneri vulcaniche? 106
Effectiveness of Ocrelizumab in Primary Progressive Multiple Sclerosis: a Multicenter, Retrospective, Real-world Study (OPPORTUNITY) 106
Abnormal Eye Movements due to Disease of the Extraocular Muscles and Their Innervation 106
Pharmacoeconomics of synthetic therapies for multiple sclerosis 106
Toxoplasma gondii and multiple sclerosis: a population-based case–control study 106
Retinal thickness and microvascular pathway in Idiopathic Rapid eye movement sleep behaviour disorder and Parkinson's disease 106
Multiple Sclerosis, COVID-19 and Vaccines: Making the Point 102
Patients with multiple sclerosis choose a collaborative role in making treatment decision: results from the Italian multicenter SWITCH study 101
A MACROSCALE MODELLING APPROACH FOR NONLINEAR ANALYSIS OF MASONRY ARCH BRIDGES 98
Risk factors for ocular surface disorders in patients with type 2 diabetes 98
Aging with multiple sclerosis: prevalence and profile of cognitive impairment 97
Retinal Nerve Fiber Layer Thickness and Higher Relapse Frequency May Predict Poor Recovery after Optic Neuritis in MS Patients 97
A post hoc evaluation of the shift in spasticity category in individuals with multiple sclerosis-related spasticity treated with nabiximols 97
Natalizumab administration in multiple sclerosis patients during active SARS-CoV-2 infection: a case series 95
Cerebrospinal fluid neurofilament light chains predicts early disease-activity in Multiple Sclerosis 95
Microbiological characteristics of the ocular surface in the patients with discoid lupus erythematosus. 93
Risk of Persistent Disability in Patients with Pediatric-Onset Multiple Sclerosis 93
Incidence of late onset multiple sclerosis in Italy: a population-based study 92
Multiple Sclerosis in the Mount Etna region: possible role of volcanogenic trace elements 92
Static postural control disturbances among the different multiple sclerosis phenotypes: A Neurocom Balance Manager®evaluation study 92
Cardiovascular autonomic individual profile of relapsing-remitting multiple sclerosis patients and risk of extending cardiac monitoring after first dose fingolimod 92
Clinical effectiveness of different natalizumab interval dosing schedules in a large Italian population of patients with multiple sclerosis 92
The ocular surface in patients video display terminal (VDT) 91
Rituximab vs Ocrelizumab in Relapsing-Remitting Multiple Sclerosis 90
Clinical and patient determinants of changing therapy in relapsing-remitting multiple sclerosis (SWITCH study) 90
Pregnancy planning and management for women with multiple sclerosis: what has changed over the last 15 years? An Italian single-center experience 90
eMSQOL-29: Prospective validation of the abbreviated, electronic version of MSQOL-54 89
COVID-19 outbreak in Italy: an opportunity to evaluate extended interval dosing of ocrelizumab in MS patients 89
Early reduction of retinal thickness predicts physical and cognitive disability in newly diagnosed multiple sclerosis patients: results from a cross-sectional study 87
The effects of blood glucose regulation onn the microbiota ocular in Type II diabetic subjects 87
The efficacy of natalizumab and fingolimod on cognition in relapsing-remitting multiple sclerosis patients 86
The clinical value of Coop/Wonca charts in assessment of HRQoL in a large cohort of relapsing-remitting multiple sclerosis patients: Results of a multicenter study 85
WII may improve physical abilities in multiple sclerosis: a randomized single blind study 85
Microbiology synergism between tear substitutes and symbiotic treatment of patients with irritable bowel syndrome 84
Pregnancy and the Postpartum Period in Women With Relapsing-Remitting Multiple Sclerosis Treated With Old and New Disease-Modifying Treatments: A Real-World Multicenter Experience 84
Objective evaluation of Nintendo Wii Fit Plus balance program training on postural stability in Multiple Sclerosis patients: a pilot study 83
Lesion load may predict long-term cognitive dysfunction in multiple sclerosis patients 82
The mixture of bifidobacterium associated with fructooligosaccharides reduces the damage of the ocular surface 82
Pain Following the Use of Anesthesia Formulation Among Individuals Undergoing Cataract Surgery: A Randomized Controlled Trial 82
Prevalence and incidence of cognitive impairment in multiple sclerosis: a population-based survey in Catania, Sicily 81
Long-term Cognitive Outcomes and Socioprofessional Attainment in People With Multiple Sclerosis With Childhood Onset 80
New strategies to manage the safety of cladribine in patients with multiple sclerosis 80
Effects of THC/CBD oromucosal spray on spasticity-related symptoms in people with multiple sclerosis: results from a retrospective multicenter study 79
Rituximab for the treatment of multiple sclerosis: a review 79
Pharmacokinetic drug evaluation of daclizumab for the treatment of relapsing-remitting multiple sclerosis 76
Totale 11.421
Salva come PNG Salva come JPEG
Categoria #
all - tutte 45.031
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 45.031
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022541 0 93 13 22 90 4 88 18 18 4 19 172
2022/20231.281 87 90 29 138 100 196 16 269 282 12 50 12
2023/2024708 34 155 41 32 27 159 11 56 8 12 109 64
2024/20252.725 61 376 137 148 499 399 120 60 222 270 219 214
2025/20266.651 393 590 983 438 984 1.273 638 191 284 367 246 264
2026/2027423 207 216 0 0 0 0 0 0 0 0 0 0
Totale 13.299